Quratis (XKRX:348080) Debt-to-Revenue : 53.14 (As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Quratis Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Quratis's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₩6,800.7 Mil. Quratis's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₩10,666.4 Mil. Quratis's annualized Revenue for the quarter that ended in Dec. 2024 was ₩328.7 Mil. Quratis's annualized Debt-to-Revenue for the quarter that ended in Dec. 2024 was 53.14.

Quratis Debt-to-Revenue Historical Data

The historical data trend for Quratis's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quratis Debt-to-Revenue Chart

Quratis Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Debt-to-Revenue

Get a 7-Day Free Trial

189.80

14.45

3.29

20.86

46.73

Quratis Quarterly Data
	Dec18	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Debt-to-Revenue	Get a 7-Day Free Trial														177.10	69.34	37.49	62.48	53.14

Competitive Comparison of Quratis's Debt-to-Revenue

For the Biotechnology subindustry, Quratis's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Quratis's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Quratis's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Quratis's Debt-to-Revenue falls into.

Save Embed

;

Save Embed

;

Quratis Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Quratis's Debt-to-Revenue for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(6800.697	+	10666.35)	/	373.797
	=	46.73

Quratis's annualized Debt-to-Revenue for the quarter that ended in Dec. 2024 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(6800.697	+	10666.35)	/	328.712
	=	53.14

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2024) Revenue data.

Quratis Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Quratis's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Quratis Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quratis Inc (XKRX:348080) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

306, 13, Teheran-ro 64-gil, Gangnam-gu, Seoul, KOR

Website

http://quratis.com

Quratis Inc operates as a developer of vaccines and therapies designed to treat tuberculosis. The company develops youth and adults tuberculosis vaccines, messenger ribonucleic acids, and other related immune-related vaccines.

Quratis Headlines

No Headlines